<DOC>
	<DOC>NCT02431091</DOC>
	<brief_summary>The purpose of this study is to determine the sensitivity and specificity of the use of optical coherence tomography to detect HIV-associated neurocognitive disorder compared to MRI and usual cognitive screening tools.</brief_summary>
	<brief_title>Evaluation of the Role of OCT in the Detection of HIV-associated Neurocognitive Disorder</brief_title>
	<detailed_description />
	<mesh_term>Dementia</mesh_term>
	<mesh_term>Neurocognitive Disorders</mesh_term>
	<mesh_term>AIDS Dementia Complex</mesh_term>
	<criteria>HIV infection Antiretroviral treatment Undetectable plasmatic HIV viral load (viral load&lt;50 copies/ml) for at least 6 months Ability to understand and give approved consent Any present or past ophthalmologic illness that may impair OCT results Previous cerebral infection with sequel Previous cerebrovascular disease with sequel Severe psychiatric illness Active alcohol or drug abuse Active chronic hepatitis C Inability to perform french cognitive assessment Inability to perform a MRI Inability to perform a lumbar puncture</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Optical Coherence Tomography</keyword>
</DOC>